{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:19:49Z","timestamp":1789057189735,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006507","name":"FIOCRUZ","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.04.050","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T21:16:29Z","timestamp":1430169389000},"page":"4288-4291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium"],"prefix":"10.1016","volume":"33","author":[{"given":"Diogo A.","family":"Mattos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon V.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane P.","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda R.","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.04.050_bib0115","series-title":"Molecular biology of the flavivirus","first-page":"1","article-title":"The molecular biology of yellow fever virus","author":"Kummerer","year":"2006"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.050_bib0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cll.2010.01.001","article-title":"Yellow fever: a reemerging threat","volume":"30","author":"Gardner","year":"2010","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.vaccine.2015.04.050_bib0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2015.04.050_bib0130","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.vaccine.2004.10.035","article-title":"Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity","volume":"23","author":"Freire","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.050_bib0135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine\u2014how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"Barrett","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"9276","key":"10.1016\/j.vaccine.2015.04.050_bib0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.vaccine.2015.04.050_bib0145","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity","volume":"28","author":"Monath","year":"2010","journal-title":"Vaccine"},{"issue":"51","key":"10.1016\/j.vaccine.2015.04.050_bib0150","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1016\/j.vaccine.2010.10.015","article-title":"Is it time for a new yellow fever vaccine?","volume":"28","author":"Hayes","year":"2010","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2015.04.050_bib0155","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1016\/j.vaccine.2014.06.045","article-title":"Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing. The Influenza Cell Culture Working Group","volume":"32","author":"Donis","year":"2014","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2015.04.050_bib0160","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1016\/j.vaccine.2009.06.023","article-title":"Production of yellow fever virus in microcarrier-based Vero cell cultures","volume":"27","author":"Souza","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.04.050_bib0165","first-page":"773","article-title":"The measurement of proliferation in tissue cultures by enumeration of cell nuclei","volume":"11","author":"Sanford","year":"1951","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.04.050_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1702(01)00273-8","article-title":"Construction, characterization and immunogenicity of recombinant yellow fever 17 D-dengue type 2 viruses","volume":"79","author":"Caufour","year":"2001","journal-title":"Virus Res"},{"issue":"24","key":"10.1016\/j.vaccine.2015.04.050_bib0175","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.vaccine.2014.02.036","article-title":"Development of a membrane adsorber based capture step for the purification of yellow fever virus","volume":"32","author":"Pato","year":"2014","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2015.04.050_bib0180","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.vaccine.2014.02.022","article-title":"Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods","volume":"32","author":"Thomassen","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.050_bib0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00253-009-2064-y","article-title":"A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor","volume":"85","author":"Rourou","year":"2009","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.050_bib0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00253-010-2742-9","article-title":"MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation","volume":"88","author":"Genzel","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2015.04.050_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/586363","article-title":"Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor","author":"Arifin","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.vaccine.2015.04.050_bib0200","unstructured":"Guertin PM. & Crowell JM, US Patent No. 043013, 2010."},{"issue":"46","key":"10.1016\/j.vaccine.2015.04.050_bib0205","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2009.06.020","article-title":"Suspension Vero cell cultures as a platform for viral vaccine production","volume":"27","author":"Paillet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.050_bib0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1472-6750-12-79","article-title":"Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells","volume":"12","author":"Lohr","year":"2012","journal-title":"BMC Biotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.050_bib0215","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.vaccine.2012.10.070","article-title":"PER.C6\u00ae cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine","volume":"31","author":"Sanders","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.050_bib0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-62703-733-4_23","article-title":"Vaccine production: upstream processing with adherent or suspension cell lines","volume":"1104","author":"Genzel","year":"2014","journal-title":"Methods Mol Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15005149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15005149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T02:54:36Z","timestamp":1537671276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15005149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":22,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15005149"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}